409
Views
0
CrossRef citations to date
0
Altmetric
Letter

Letter from the Editor

References

  • Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. (2014). Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest, 43, 54–68
  • Ávalos-Martínez CE, Rodríguez-Alba JC, Berrón-Ruiz L et al. (2013). Measurement of Suppressor Activity of T CD4+CD25+ T Reg Cells Using Bromodeoxyuridine Incorporation Assay. Immunol Invest, 42, 369–81
  • Brar JE, Nader ND. (2014). Immune minimization strategies in renal transplantation. 43, 807–18
  • Callado MRM, Barroso MNdA, Alves VM, et al. (2014). Antinuclear antibodies: Two-step detection strategy. Immunol Invest, 43, 86–95
  • Calusic M, Grubic Z, Stingl K, et al. (2012). Diversity of HLA-B*35 alleles and haplotypesamong Croatians. Immunol Invest, 41, 856–63
  • Choi YS, Jeong JA, Lim DS. (2012). Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest, 41, 214–29
  • de Azevedo MTA, Saad STO, Gilli SCO. (2013). IL4 and IFNalpha generation of dendritic cells reveals great migratory potential and NFkB and cJun expression in IL4DCs. Immunol Invest, 42, 711–25
  • Devasthanam AS, Tomasi TB. (2014). Dicer in immune cell development and function. Immunol Invest, 43, 182–95
  • Devasundaram S, Deenadayalan A, Raja A. (2014). In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis. Immunol Invest, 43, 137–59
  • Dziak R. (2013). The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. Immunol Invest, 42, 510–8
  • Ebrahimi, A, Rahim F. (2014). Recent immunomodulatory strategies in transplantation. Immunol Invest 43, 829–37
  • García-Cordero J, Carrillo-Halfon S, León-Juárez M, et al. (2014). Generation and characterization of a rat monoclonal antibody against the RNA polymerase protein from Dengue Virus-2. Immunol Invest, 43, 28–40
  • Garfias Y, Zaga-Clavellina V, Vadillo-Ortega F, et al. (2011). Amniotic membrane is an immunosuppressor of peripheral blood mononuclear cells. Immunol Invest, 40, 183–96
  • Habibagahi M, Razmkhah M, Niri NM, et al. (2013). Combined 4-1BB and CD28 costimulation could unleash lymphocytes from immunosuppression induced by adipose derived stem cell soluble products. Immunol Invest, 42, 307–23
  • Hauser J, Hsu B, Nader ND. (2013). Inflammatory Processes in Complex Regional Pain Syndromes. Immunol Invest, 42, 263–72
  • Hu, K, Zhou H, Zheng G, et al. (2014). Imbalance of different types of CD4+FoxP3+ T cells in renal transplant recipients. Immunol Invest, 43, 838–50
  • Inn K-S, Lee G-J, Quan F-S. (2014). A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice. Immunol Invest, 43, 236–54
  • Jackson SR, Berrien-Elliott MM, Meyer JM, et al. (2013). CD8+ T Cell Exhaustion During Persistent Viral Infection is Regulated Independently of the Virus-Specific T Cell Receptor. Immunol Invest, 42, 204–20
  • Kadkhodazadeh M, Baghani Z, Ebadian AR, et al. (2013). IL-17 Gene Polymorphism Is Associated with Chronic Periodontitis and Peri-implantitis in Iranian Patients: A Cross-Sectional Study. Immunol Invest, 42, 156–63
  • Karimi MH, Hejr S, Geramizadeh B, et al. (2014). Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients. Immunol Invest, 43, 69–85
  • Kim S-J, Ha G-H, Kim S-H, Kang C-D. (2014). Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells. Immunol Invest, 43, 517–34
  • Kim YH, Kim TH, Kang SW, et al. (2013). Association between a TGFBR2 gene polymorphism (rs2228048, Asn389Asn) and acute rejection in Korean kidney transplantation recipients. Immunol Invest, 42, 285–95
  • Kumar, V, Kumar A. (2014). Immunological aspects of corneal transplantation. Immunol Invest 43, 888–901
  • Laftavi, MR., Sharma R., Feng L., et al. 2014. Induction therapy in renal transplant recipients: A review. 43, 790–806
  • Lee J, Lim KT. (2013). Protection against cyclophosphamide-induced myelosuppression by ZPDC glycoprotein (24 kDa). Immunol Invest, 42, 61–80
  • Lim J-Y, Cho B-S, Min C-K, et al. (2014). Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunol Invest, 43, 41–53
  • Machino T, Okoshi Y, Miyake Y, et al. (2012). HLA-C matching status does not affect rituximab-mediated antibody-dependent cellular cytotoxicity by allogeneic natural killer Cells. Immunol Invest, 41, 831–46
  • Maguire, O., Tario Jr. J.D., Shanahan T.C., et al. (2014). Flow cytometry and solid organ transplantation: A perfect match.43, 756–74
  • Manjili, MH, Toor AA. 2014. Etiology of GVHD: Alloreactivity or impaired cellular adaptation? Immunol Invest 43, 851–7
  • Ostrov BE, Amsterdam D. (2013). The interference of monoclonal antibodies with laboratory diagnosis: Clinical and diagnostic implications. Immunol Invest, 42, 673–90
  • Pankewycz, O, Soliman K., Laftavi MR. (2014). The increasing clincal importance of alloantibodies in kidney transplantation. 43, 775–89
  • Park S, Kang S, Min KH, et al. (2013). Age-Associated Changes in MicroRNA Expression in Bone Marrow Derived Dendritic Cells. Immunol Invest, 42, 179–90
  • Qadri Q, Rasool R, Afroze D, et al. (2014). Study of TLR4 and IL-8 Gene Polymorphisms in H.pylori-Induced Inflammation in Gastric Cancer in an Ethnic Kashmiri Population. Immunol Invest, 43, 324–36
  • Raza A, Firasat S, Khaliq S, et al. (2013). HLA class I and II polymorphisms in the Gujjar population from Pakistan. Immunol Invest, 42, 691–700
  • Rey, D., Vargas-Alarcon G., Areces C., et al. (2014). Mixtec mexican amerindians: An HLA alleles study for america peopling, pharmacogenomics and transplantation. 43, 738–55
  • Samasca G, Sur G, Lupan I. (2013). Current trends and investigative developments in celiac disease. Immunol Invest, 42, 273–84
  • Shuang G, Yu S, Weixiao G, et al. (2011). Immunosuppressive activity of florfenicol on the immune responses in mice. Immunol Invest, 40, 356–66
  • Soliman, K., Mogadam E, Laftavi M., et al. (2014). Long–term outcomes following sirolimus conversion after renal transplantation. Immunol Invest 43, 819–28
  • Song S-S, Yuan P-F, Chen J-Y, et al. (2014). TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties. Immunol Invest, 43, 360–9
  • Souza PPC, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immunol Invest, 42, 555–622
  • Tunceroglu H, Shah A, Porhomayon J, Nader ND. (2013). Biomarkers of Lung Injury in Critical Care Medicine: Past, Present, and Future. Immunol Invest, 42, 247–61
  • Velaga S, Ukena SN, Hopting M, et al. (2013). Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. Immunol Invest, 42, 18–35
  • Wong P, Pongcharoen S, Pangwangthong K, et al. (2012). Evaluation of a cryopreservation procedure to set up a new bone marrow transplant unit using lymphocyte proliferation test. Immunol Invest, 41, 97–103
  • Yan G, Xi Y, Xu S, et al. (2013). Inhibition of accelerated rejection mediated by alloreactive CD4(+) memory T cells and prolonged allograft survival by arsenic trioxide. Immunol Invest, 42, 438–54

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.